When the birth, the ICU stay, or the diagnosis becomes the trauma

Some of the people who reach out to us were not hurt in a war zone or a car accident. They were hurt in a hospital, often while everyone around them was doing their job. A labor that turned into an emergency. A baby whisked to the NICU. A week on a ventilator. A heart attack at 48. A cancer scan read aloud in a hallway.

Afterward, people often hear some version of “but everyone is fine now.” Yet their body does not seem to agree. They may replay the moment the room filled with people, avoid the hospital parking garage, lose sleep before every follow-up appointment, or feel numb holding the baby they fought so hard for. If that sounds familiar, you are not being dramatic, and you are not alone. Trauma is defined by how an event was experienced, not only by how it ended on paper.

How common PTSD after birth and hospital care really is

The numbers are larger than most people are told. A 2017 systematic review and meta-analysis in the Journal of Affective Disorders (Yildiz, Ayers, and Phillips) pooled 59 studies of more than 24,000 people. It found PTSD after birth in about 4.0% of women in community samples and about 18.5% of women in high-risk groups, such as those with severe complications or preterm births. A larger 2022 meta-analysis in Clinical Psychology Review (Heyne and colleagues), covering 154 studies and 54,711 parents, estimated birth-related PTSD in 4.7% of mothers and 1.2% of fathers, with clinically significant posttraumatic stress symptoms in 12.3% of mothers. A 2024 review in the American Journal of Obstetrics & Gynecology (Horsch and colleagues) estimated that childbirth-related PTSD affects roughly 6.6 million mothers and 1.7 million fathers or co-parents worldwide each year, and noted that it is still not routinely screened for.

Hospital care outside of birth carries similar risk. A 2015 meta-analysis in Critical Care Medicine (Parker and colleagues) pooled 36 cohorts of 4,260 intensive care survivors and found clinically important PTSD symptoms in about one in five at one year. A 2012 meta-analysis in PLOS ONE (Edmondson and colleagues) found clinically significant PTSD symptoms in about 12% of people after a heart attack or unstable angina, and those symptoms were associated with roughly double the risk of a later cardiac event or death.

Why a medical setting can itself be a trigger

For most trauma, the reminders are outside the clinic. For medical trauma, the clinic is the reminder. The beep of a monitor, the squeeze of a blood pressure cuff, lying flat, the smell of antiseptic, a stranger in scrubs leaning over you: any of these can send the nervous system straight back to the worst day.

The research on what makes a birth traumatic points in the same direction. A 2016 meta-analysis in Psychological Medicine (Ayers and colleagues) found that the birth factor most strongly associated with later PTSD was a negative subjective experience of the birth, more than the medical details, along with feeling unsupported and dissociating during labor. In the ICU research, frightening memories of the ICU stay were among the identified risk factors. In other words, feeling helpless, unheard, or terrified in a medical room is part of what leaves the mark. That is worth taking seriously before anyone places an IV.

How we try to make an infusion room feel safe and controllable

We cannot make an IV infusion feel like home, and we will not pretend otherwise. What we can do is hand back as much control as possible. Before a first infusion, we can walk you through the room, show you the monitor and what its sounds mean, and explain each step before it happens. You can choose which arm we use, whether you sit up or recline, whether the eye mask goes on, the lighting, and the music or quiet. We tell you before we touch you, and you can decline reassuring touch altogether. We agree on a stop signal in advance. If you use it, we respond, and the infusion can be slowed or paused. You never have to explain why something bothers you.

For trauma-sensitive patients, we generally start with a lower dose and titrate more slowly. Some people bring their therapist or plan an integration session soon after; see can my therapist attend my session. Ketamine’s dissociative effects can feel unsettling for someone who dissociated during a birth or an emergency, so we talk about that beforehand; understanding dissociation during ketamine and managing anxiety during a session go deeper. Our broader approach is described in trauma-informed ketamine care.

Marla Peterson, CRNA, oversees every infusion, with anesthesia-level monitoring throughout. A clinician is in the room, and the team is on-site throughout. For some people, the fact that the monitoring is there to protect them, and that they can see it and ask about it, becomes part of what feels different this time.

How birth trauma relates to postpartum depression and anxiety

Birth-related PTSD often travels with depression. The 2016 Ayers meta-analysis found postpartum PTSD highly correlated with depression (r = 0.60), and the 2024 Horsch review lists postpartum depression among the risk factors for childbirth-related PTSD. They are still different conditions. PTSD centers on reliving, avoidance, and feeling on guard; postpartum depression centers on low mood and loss of interest; postpartum anxiety centers on persistent worry. Getting the right name matters, because the first-line treatments differ. Our articles on ketamine for postpartum depression and ketamine for postpartum anxiety cover those conditions in their own right.

You may see headlines about a 2024 trial in The BMJ (Wang and colleagues). In 364 women in China with symptoms of prenatal depression, a single low dose of esketamine given after the umbilical cord was clamped reduced major depressive episodes at 42 days to 6.7%, compared with 25.4% on placebo, with more frequent but transient side effects such as dizziness. That is a promising depression-prevention finding, in a hospital setting, with a related drug. It did not study birth trauma or PTSD.

What the ketamine evidence does and doesn't cover

Ketamine is FDA-approved as an anesthetic; its use for PTSD, including PTSD after birth or medical care, is off-label. At low doses, ketamine blocks NMDA glutamate receptors, which is followed by a burst of glutamate signaling and a window of increased synaptic plasticity. The hope is that this window makes it easier for rigid fear responses to shift, especially alongside therapy. That remains a working hypothesis.

The trials that exist are in adults with chronic PTSD from a range of causes. A 2014 randomized trial in JAMA Psychiatry (Feder and colleagues) found that a single ketamine infusion in 41 people rapidly reduced PTSD symptoms at 24 hours compared with midazolam. A 2021 trial by the same group in the American Journal of Psychiatry gave 30 adults six infusions over two weeks; 67% of the ketamine group responded, compared with 20% on midazolam. But a 2022 trial in Neuropsychopharmacology (Abdallah and colleagues) of 158 veterans and service members found ketamine no better than placebo on PTSD symptoms. We are not aware of any published trial of ketamine specifically for birth trauma or medical trauma.

The 2023 VA/DoD Clinical Practice Guideline for PTSD strongly recommends trauma-focused psychotherapies, namely cognitive processing therapy, EMDR, or prolonged exposure, and suggests against ketamine for PTSD, with very low confidence in the evidence. The Horsch review likewise names trauma-focused cognitive behavioral therapy and EMDR as the treatments to aim for, while noting that evidence on how best to treat childbirth-related PTSD is still limited. So trauma-focused therapy comes first. For some people who have not improved enough with it, ketamine may be a reasonable support, not a replacement; ketamine and EMDR integration describes how the two can be sequenced.

Breastfeeding, physical recovery, and timing

If you are breastfeeding, any decision about ketamine involves your OB and your pediatrician. Published data on ketamine in breast milk are limited, so this is not a routine yes, and we will not move forward without that coordination. We do not start an elective ketamine series during pregnancy. Our article on ketamine during pregnancy and breastfeeding explains our approach in detail.

Physical recovery matters too. After a cesarean, a hemorrhage, a cardiac event, or a long ICU stay, your body may still be healing, and you may be on new medications. We want your OB or primary clinician to weigh in first, and we will ask about blood pressure, heart history, and current medications. Please do not start, stop, or change any medication on your own; talk to your prescribing provider. Timing is individual. For many people, it makes sense to establish trauma-focused therapy first and consider ketamine only if progress stalls.

Honest expectations

Ketamine does not erase what happened, and it does not replace trauma-focused therapy. Some people do not respond. For those who do, the effect may fade; in the 2021 Feder trial, responders kept their response for a median of 27.5 days after the two-week series. Sessions are $475 each, and insurance generally does not cover off-label use.

What we can offer is a careful, unhurried conversation about whether ketamine fits your situation, a room where you set more of the terms than you did last time, and honest advice if we think another path makes more sense. For related reading, our trauma and PTSD pages gather articles such as ketamine for PTSD.